Poseida Therapeutics, Inc.Poseida Therapeutics, Inc.Poseida Therapeutics, Inc.

Poseida Therapeutics, Inc.

No trades
See on Supercharts

Price target

9.500.000.00%
The 2 analysts offering 1 year price forecasts for PSTX have a max estimate of — and a min estimate of —.

Analyst rating

Based on 5 analysts giving stock ratings to PSTX in the past 3 months.

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


PSTX EPS for the last quarter is 0.21 USD despite the estimation of −0.42 USD. In the next quarter EPS is expected to reach −0.33 USD. Track more of Poseida Therapeutics, Inc. financials and stay on top of what is up with the company.
In the next quarter Poseida Therapeutics, Inc. revenue is expected to reach ‪21.25 M‬ USD. Check out Poseida Therapeutics, Inc. revenue and earnings and make informed decisions.
According to analysts, PSTX price target is 9.50 USD with a max estimate of 10.00 USD and a min estimate of 9.00 USD. Check if this forecast comes true in a year, meanwhile watch Poseida Therapeutics, Inc. stock price chart and keep track of the current situation with PSTX news and stock market news.
We've gathered opinions of 5 analysts rating PSTX stock in the past 3 months. Most of them backed up the neutral trend, and after taking into account other opinions, the overall rating was calculated as neutral. Note that it's not a trading advice — your own analysis is still required.